79 related articles for article (PubMed ID: 32482115)
1. The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells.
Zhang X; Liu L; Tang M; Li H; Guo X; Yang X
Drug Dev Ind Pharm; 2020 Jul; 46(7):1150-1162. PubMed ID: 32482115
[No Abstract] [Full Text] [Related]
2. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer
Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X
Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754
[TBL] [Abstract][Full Text] [Related]
3. Targeting SOD1 via RNAi with PEGylated graphene oxide nanoparticles in platinum-resistant ovarian cancer.
Szénási A; Sivasudhan E; Du H; Zhang P; Huang J; Zhang Z; Rocha S; Wang M
Cancer Gene Ther; 2023 Nov; 30(11):1554-1568. PubMed ID: 37582934
[TBL] [Abstract][Full Text] [Related]
4. Exosome Mediated Cytosolic Cisplatin Delivery Through Clathrin-Independent Endocytosis and Enhanced Anti-cancer Effect
Zhou G; Gu Y; Zhu Z; Zhang H; Liu W; Xu B; Zhou F; Zhang M; Hua K; Wu L; Ding J
Front Med (Lausanne); 2022; 9():810761. PubMed ID: 35592860
[TBL] [Abstract][Full Text] [Related]
5. Macrophages enhance cisplatin resistance in gastric cancer through the transfer of circTEX2.
Qu B; Liu J; Peng Z; Xiao Z; Li S; Wu J; Li S; Luo J
J Cell Mol Med; 2023 Dec; 28(5):e18070. PubMed ID: 38102848
[TBL] [Abstract][Full Text] [Related]
6. Human plasma derived exosomes: Impact of active and passive drug loading approaches on drug delivery.
Gul R; Bashir H; Sarfraz M; Shaikh AJ; Bin Jardan YA; Hussain Z; Bin Asad MHH; Gulzar F; Guan B; Nazir I; Amirzada MI
Saudi Pharm J; 2024 Jun; 32(6):102096. PubMed ID: 38757071
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of exosomes encapsulated recombinant Interleukin-29 for its in vitro anticancer studies.
Fujimura NA; Fatima SE; Ahmed N; Akram M; Tahir S; Khan MA; Amirzada I; Nadeem T; Bashir H; Malik K
J Biotechnol; 2023 Aug; 373():24-33. PubMed ID: 37394182
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Drug Loading Method on the Drug Distribution and Biological Efficacy of Exosomes.
Kumar DN; Chaudhuri A; Kumar D; Singh S; Agrawal AK
AAPS PharmSciTech; 2023 Aug; 24(6):166. PubMed ID: 37552397
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery
Guo L; Zhang Y; Wei R; Zhang X; Wang C; Feng M
Theranostics; 2020; 10(15):6581-6598. PubMed ID: 32550891
[No Abstract] [Full Text] [Related]
10. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.
Zhou W; Zhou Y; Chen X; Ning T; Chen H; Guo Q; Zhang Y; Liu P; Zhang Y; Li C; Chu Y; Sun T; Jiang C
Biomaterials; 2021 Jan; 268():120546. PubMed ID: 33253966
[TBL] [Abstract][Full Text] [Related]
11. A human chorionic gonadotropin (hCG) delivery platform using engineered uterine exosomes to improve endometrial receptivity.
Hajipour H; Farzadi L; Roshangar L; Latifi Z; Kahroba H; Shahnazi V; Hamdi K; Ghasemzadeh A; Fattahi A; Nouri M
Life Sci; 2021 Jun; 275():119351. PubMed ID: 33737084
[TBL] [Abstract][Full Text] [Related]
12. Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance.
Parashar D; Geethadevi A; McAllister D; Ebben J; Peterson FC; Jensen DR; Bishop E; Pradeep S; Volkman BF; Dwinell MB; Chaluvally-Raghavan P; James MA
NPJ Precis Oncol; 2021 Mar; 5(1):16. PubMed ID: 33654182
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell-derived exosome-entrapped paclitaxel can enhance its anti-tumor effect.
Han D; Wang K; Zhang T; Gao GC; Xu H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5703-5713. PubMed ID: 32495906
[TBL] [Abstract][Full Text] [Related]
14. Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications.
Zhang Y; Bi J; Huang J; Tang Y; Du S; Li P
Int J Nanomedicine; 2020; 15():6917-6934. PubMed ID: 33061359
[TBL] [Abstract][Full Text] [Related]
15. Exosomes in diagnostic and therapeutic applications of ovarian cancer.
Bhavsar D; Raguraman R; Kim D; Ren X; Munshi A; Moore K; Sikavitsas V; Ramesh R
J Ovarian Res; 2024 May; 17(1):113. PubMed ID: 38796525
[TBL] [Abstract][Full Text] [Related]
16. Applications of emerging extracellular vesicles technologies in the treatment of inflammatory diseases.
Lou K; Luo H; Jiang X; Feng S
Front Immunol; 2024; 15():1364401. PubMed ID: 38545101
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade.
Moghassemi S; Dadashzadeh A; Sousa MJ; Vlieghe H; Yang J; León-Félix CM; Amorim CA
Bioact Mater; 2024 Jun; 36():126-156. PubMed ID: 38450204
[TBL] [Abstract][Full Text] [Related]
18. Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes.
Wang B; Cheng D; Ma D; Chen R; Li D; Zhao W; Fang C; Ji M
Cell Commun Signal; 2024 Jan; 22(1):21. PubMed ID: 38195554
[TBL] [Abstract][Full Text] [Related]
19. 17β-Estradiol-Loaded Exosomes for Targeted Drug Delivery in Osteoporosis: A Comparative Study of Two Loading Methods.
Gholami Farashah MS; Javadi M; Soleimani Rad J; Shakouri SK; Asnaashari S; Dastmalchi S; Nikzad S; Roshangar L
Adv Pharm Bull; 2023 Nov; 13(4):736-746. PubMed ID: 38022800
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
